Cloning and expression of a novel variant of human interferon-gamma cDNA. 1985

T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek

A cDNA library was prepared from the poly(A) mRNA isolated from human peripheral blood lymphocytes which were induced by combined treatment with phytohemagglutinin and a phorbol ester. Recombinant plasmids containing human interferon-gamma (HuIFN-gamma) cDNAs were identified by the oligonucleotide-hybridization method. Nucleotide sequence analysis showed that the nucleotide and amino-acid sequences of HuIFN-gamma cDNA in plasmid pIFN gamma-G4 differed from the published data at amino acid position 9 (CAA for glutamine versus AAA for lysine). The cDNA in plasmid pIFN gamma-G4 was expressed under control of the simian virus 40 early promoter in monkey COS cells and a biologically active HuIFN-gamma was secreted from the cells. The cDNA was also inserted into an expression vector carrying an E. coli tryptophan promoter and was expressed in E. coli. The results suggest that the conversion from lysine to glutamine at amino acid position 9 might not affect the specific activity of HuIFN-gamma.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011061 Poly A A group of adenine ribonucleotides in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. Adenine Polynucleotides,Polyadenylic Acids,Poly(rA),Polynucleotides, Adenine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli

Related Publications

T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
December 1989, Proceedings of the National Academy of Sciences of the United States of America,
T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
November 1997, International archives of allergy and immunology,
T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
April 1990, Biochemical and biophysical research communications,
T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
October 1994, The Journal of biological chemistry,
T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
January 1994, Immunogenetics,
T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
November 1989, Proceedings of the National Academy of Sciences of the United States of America,
T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
June 1992, Journal of interferon research,
T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
January 1990, Lymphokine research,
T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
March 1983, Nucleic acids research,
T Nishi, and T Fujita, and C Nishi-Takaoka, and A Saito, and T Matsumoto, and M Sato, and T Oka, and S Itoh, and Y K Yip, and J Vilcek
January 1985, Journal of interferon research,
Copied contents to your clipboard!